Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer …
Read More
Exciting News! AliveCor is giving away AliveCor® Heart Monitors to the first 100 people that enter and pick up their AliveCor at our Get in Rhythm, Stay in Rhythm AF Patient Conference! With conference early registration at ONLY $79, and the AliveCor Heart Monitor costing $75, this is pretty much a no-brainer! Register Today — …
Read More
Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW …
Read More
Get a special discount on the FDA-approved AfibAlert® heart monitor for detecting atrial fibrillation. Lohman Technologies is making this special discount available for the StopAfib.org patient community for a limited time only, so please act quickly. To learn more, see: Special Discount on AfibAlert® Standalone Heart Monitor for Detecting Atrial Fibrillation.
Read More
My AFib Experience™ (www.myafibexperience.org) is an innovative and unique online community that can help people understand atrial fibrillation, learn how to better manage it, and connect with others who also experience it. A collaboration of the American Heart Association/American Stroke Association and StopAfib.org, with support from Janssen Pharmaceuticals, Inc., MyAFibExperience is designed to help people …
Read More
The VICTORY AF (Evaluation of Multielectrode Phased RF Technology in Persistent AF) Trial, sponsored by Medtronic, is studying patients undergoing a catheter ablation with Medtronic's Phased Radiofrequency (RF) system. To learn more, see: VICTORY AF Trial Studies Phased Radiofrequency (RF) System for Persistent and Longstanding Persistent Atrial Fibrillation
Read More
On December 2, we’re joining a national day of generosity, #GivingTuesday. It’s a day when you can make a big impact on StopAfib.org and our mission to keep you informed so that you can get your life back and to wipe out afib-related strokes worldwide. With your help, we’ll raise funds to support research, to …
Read More
Atrial fibrillation is the most common irregular heart rhythm that starts in the atria. While it is often a mere annoyance, it can also be responsible for life-threatening medical emergencies that result in cardiac arrest, stroke and sudden death. Take advantage of the opportunity to get your atrial fibrillation questions answered by afib experts from …
Read More
Learn about new treatment options, including the Hybrid Maze procedure, in a Free LiveCast Seminar from St. Helena Arrhythmia Center on November 18, 2014 6:30 – 8:00 PM PST. The Hybrid Maze is a new minimally invasive procedure for atrial fibrillation. Patients benefit from better outcomes, a shorter hospital stay, and quicker recovery. Dr. Gan …
Read More
Biosense Webster, Inc. and StopAfib.org have teamed up to raise awareness of atrial fibrillation and available treatment options through Get SMART About AfibSM, an interactive web experience. Learn more at: Biosense Webster Teams Up with StopAfib.org to Challenge Americans to Get SMART About AfibSM
Read More